BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 18677410)

  • 41. Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphoma.
    Tan Q; Brunetti L; Rousseaux MWC; Lu HC; Wan YW; Revelli JP; Liu Z; Goodell MA; Zoghbi HY
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1511-E1519. PubMed ID: 29382756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Notch1/c-Myc pathway in T cell leukemia.
    Sharma VM; Draheim KM; Kelliher MA
    Cell Cycle; 2007 Apr; 6(8):927-30. PubMed ID: 17404512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
    Trinquand A; Tanguy-Schmidt A; Ben Abdelali R; Lambert J; Beldjord K; Lengliné E; De Gunzburg N; Payet-Bornet D; Lhermitte L; Mossafa H; Lhéritier V; Bond J; Huguet F; Buzyn A; Leguay T; Cahn JY; Thomas X; Chalandon Y; Delannoy A; Bonmati C; Maury S; Nadel B; Macintyre E; Ifrah N; Dombret H; Asnafi V
    J Clin Oncol; 2013 Dec; 31(34):4333-42. PubMed ID: 24166518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An activating intragenic deletion in NOTCH1 in human T-ALL.
    Haydu JE; De Keersmaecker K; Duff MK; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Ferrando A
    Blood; 2012 May; 119(22):5211-4. PubMed ID: 22510873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
    Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
    PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis.
    Zhu YM; Zhao WL; Fu JF; Shi JY; Pan Q; Hu J; Gao XD; Chen B; Li JM; Xiong SM; Gu LJ; Tang JY; Liang H; Jiang H; Xue YQ; Shen ZX; Chen Z; Chen SJ
    Clin Cancer Res; 2006 May; 12(10):3043-9. PubMed ID: 16707600
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leukemia-specific delivery of mutant NOTCH1 targeted therapy.
    Roti G; Qi J; Kitara S; Sanchez-Martin M; Saur Conway A; Varca AC; Su A; Wu L; Kung AL; Ferrando AA; Bradner JE; Stegmaier K
    J Exp Med; 2018 Jan; 215(1):197-216. PubMed ID: 29158376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Growth factor independent-1 maintains Notch1-dependent transcriptional programming of lymphoid precursors.
    Phelan JD; Saba I; Zeng H; Kosan C; Messer MS; Olsson HA; Fraszczak J; Hildeman DA; Aronow BJ; Möröy T; Grimes HL
    PLoS Genet; 2013; 9(9):e1003713. PubMed ID: 24068942
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cutting Edge: Codeletion of the Ras GTPase-Activating Proteins (RasGAPs) Neurofibromin 1 and p120 RasGAP in T Cells Results in the Development of T Cell Acute Lymphoblastic Leukemia.
    Lubeck BA; Lapinski PE; Oliver JA; Ksionda O; Parada LF; Zhu Y; Maillard I; Chiang M; Roose J; King PD
    J Immunol; 2015 Jul; 195(1):31-5. PubMed ID: 26002977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The PIAS-like Coactivator Zmiz1 Is a Direct and Selective Cofactor of Notch1 in T Cell Development and Leukemia.
    Pinnell N; Yan R; Cho HJ; Keeley T; Murai MJ; Liu Y; Alarcon AS; Qin J; Wang Q; Kuick R; Elenitoba-Johnson KS; Maillard I; Samuelson LC; Cierpicki T; Chiang MY
    Immunity; 2015 Nov; 43(5):870-83. PubMed ID: 26522984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.
    Weng AP; Ferrando AA; Lee W; Morris JP; Silverman LB; Sanchez-Irizarry C; Blacklow SC; Look AT; Aster JC
    Science; 2004 Oct; 306(5694):269-71. PubMed ID: 15472075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia.
    Breit S; Stanulla M; Flohr T; Schrappe M; Ludwig WD; Tolle G; Happich M; Muckenthaler MU; Kulozik AE
    Blood; 2006 Aug; 108(4):1151-7. PubMed ID: 16614245
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL.
    Li X; Sanda T; Look AT; Novina CD; von Boehmer H
    J Exp Med; 2011 Apr; 208(4):663-75. PubMed ID: 21464222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Progress in research on childhood T-cell acute lymphocytic leukemia, Notch1 signaling pathway, and its inhibitors: A review.
    Fang-Fang Z; You Y; Wen-Jun L
    Bosn J Basic Med Sci; 2021 Apr; 21(2):136-144. PubMed ID: 32415821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. KDM6B protects T-ALL cells from NOTCH1-induced oncogenic stress.
    Issa N; Bjeije H; Wilson ER; Krishnan A; Dunuwille WMB; Parsons TM; Zhang CR; Han W; Young AL; Ren Z; Ge K; Wang ES; Weng AP; Cashen A; Spencer DH; Challen GA
    Leukemia; 2023 Apr; 37(4):728-740. PubMed ID: 36797416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines.
    Dohda T; Maljukova A; Liu L; Heyman M; Grandér D; Brodin D; Sangfelt O; Lendahl U
    Exp Cell Res; 2007 Aug; 313(14):3141-52. PubMed ID: 17560996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dissecting molecular mechanisms of resistance to NOTCH1-targeted therapy in T-cell acute lymphoblastic leukemia xenografts.
    Agnusdei V; Minuzzo S; Pinazza M; Gasparini A; Pezzè L; Amaro AA; Pasqualini L; Bianco PD; Tognon M; Frasson C; Palumbo P; Ciribilli Y; Pfeffer U; Carella M; Amadori A; Indraccolo S
    Haematologica; 2020 May; 105(5):1317-1328. PubMed ID: 31467126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CREBBP knockdown enhances RAS/RAF/MEK/ERK signaling in Ras pathway mutated acute lymphoblastic leukemia but does not modulate chemotherapeutic response.
    Dixon ZA; Nicholson L; Zeppetzauer M; Matheson E; Sinclair P; Harrison CJ; Irving JA
    Haematologica; 2017 Apr; 102(4):736-745. PubMed ID: 27979926
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Notch1 and IL-7 receptor signalling in early T-cell development and leukaemia.
    González-García S; García-Peydró M; Alcain J; Toribio ML
    Curr Top Microbiol Immunol; 2012; 360():47-73. PubMed ID: 22695916
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia.
    Grabher C; von Boehmer H; Look AT
    Nat Rev Cancer; 2006 May; 6(5):347-59. PubMed ID: 16612405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.